{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:20:28Z","timestamp":1780489228019,"version":"3.54.1"},"reference-count":52,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Residual neuromuscular blockade (RNB) commonly occurs when using neuromuscular blockers and increases the risk for pulmonary complications, such as airway obstruction and severe hypoxemia, in extubated patients. Rocuronium exhibits a high variability in recovery time, contributing to an increased risk for RNB. This study aimed to identify and characterize the sources of variability in rocuronium exposure and response via a population pharmacokinetic\/pharmacodynamic (PK\/PD) analysis and to apply the developed PK\/PD model to investigate clinical implications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A nonlinear mixed\u2010effect model was developed for rocuronium in patients undergoing general anaesthesia, using doses of 0.3\u20131.2\u00a0mg\/kg. Plasma concentrations and the neuromuscular block (train of four ratio) were assessed up to 6\u00a0h after dosing. The influence of age, body mass index, renal function and sex on PK and PD was explored. Simulations were performed to predict the recovery time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A two\u2010compartment model with linear elimination and an indirect sigmoid I\u2010max model was used to describe PK and PD. The transfer rate into the periphery increases with age. The predicted recovery time was significantly longer in older subjects aged 85 years (median: 2.8\u00a0h; interquartile range [IQR]: 2.18\u20134.0) compared to young adults aged 25 years (median: 2.5\u00a0h; IQR: 2.0\u20133.1) following single bolus administrations of doses \u2265 0.7\u00a0mg\/kg.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings suggest that older patients take slightly longer to recover than younger adults due to an age\u2010dependent increase in tissue uptake. However, a priori dose adjustments for rocuronium in older patients are not feasible, since age contribution is overshadowed by the overall variability in the recovery time.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.16386","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:08:11Z","timestamp":1736402891000},"page":"1692-1704","source":"Crossref","is-referenced-by-count":2,"title":["Unravelling sources of variability on rocuronium pharmacokinetics: Implications for prolonged recovery in older patients"],"prefix":"10.1111","volume":"91","author":[{"given":"Miriam S. R.","family":"Happ","sequence":"first","affiliation":[{"name":"Pharmacology and Toxicology Section, Pharmaceutical Institute University of Bonn  Bonn NRW Germany"},{"name":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics. College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro F.","family":"Pippa","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics. College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela R.","family":"Lauretti","sequence":"additional","affiliation":[{"name":"School of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo  Ribeirao Preto SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Gebhart","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics. College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Weindl","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology Section, Pharmaceutical Institute University of Bonn  Bonn NRW Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine J.","family":"Azeredo","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics. College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valvanera","family":"Vozmediano","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics. College of Pharmacy University of Florida  Orlando FL USA"},{"name":"Model Informed Development, Regulatory Development and Consulting CTI Laboratories  Covington KY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics. College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-058X","authenticated-orcid":false,"given":"Natalia V.","family":"de Moraes","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics. College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102044.2006.04862.x"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399\u20106576.2005.00634.x"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000004379"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/47.5.570"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13738"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181da832d"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542\u2010200306000\u201000006"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542\u2010200004000\u201000014"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2018.12.042"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542\u2010200305000\u201000004"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e31816d1268"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeq157"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542\u2010199711000\u201000005"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000865"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539\u2010199312000\u201000019"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2007.051"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539\u2010199504000\u201000018"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.18433\/J3RG6W"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep340"},{"key":"e_1_2_10_21_1","unstructured":"Meitheal Pharmaceuticals Inc.Neostigmine methylsulfate injection\u2014Highlights of prescribing information2021. <https:\/\/api.meithealpharma.com> Accessed: December 15 2023."},{"key":"e_1_2_10_22_1","unstructured":"Merck Sharp & Dohme LLC.BRIDION\u00ae (sugammadex) injection\u2014Highlights of prescribing information2022. <https:\/\/www.merck.com\/product\/usa\/pi_circulars\/b\/bridion> Accessed: 1December 15 2023."},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/aas.13645"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2011.04000.x"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00540\u2010018\u20102543\u20103"},{"key":"e_1_2_10_26_1","unstructured":"Hospira Inc.Rocuronium bromide injection\u2014Highlights of prescribing information2019. <https:\/\/www.pfizermedicalinformation.com\/en-us\/rocuronium-bromide-injection\/highlights> Accessed: December 18 2023."},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14539"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102044.1995.tb05990.x"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/71.2.222"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009\u20109236(95)90196\u20105"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460\u20109592.2006.02181.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12617"},{"key":"e_1_2_10_33_1","unstructured":"ASA Physical Status Classification System.2020. <https:\/\/www.asahq.org\/standards-and-practice-parameters\/statement-on-asa-physical-status-classification-system> Accessed: August 2 2023."},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2013.11.032"},{"key":"e_1_2_10_35_1","unstructured":"LIXOFT SAS.Monolix 2021R1. <https:\/\/lixoft.com\/> Accessed: July 4 2023."},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010150\u20109\u2010200905050\u201000006"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.14"},{"key":"e_1_2_10_38_1","unstructured":"LIXOFT SAS.Simulx 2023R1. <https:\/\/lixoft.com\/> Accessed: July 4 2023."},{"key":"e_1_2_10_39_1","volume-title":"Methodological studies on covariate model building in population pharmacokinetic\u2010pharmacodynamic analysis","author":"W\u00e4hlby U","year":"2002"},{"key":"e_1_2_10_40_1","unstructured":"R Core Team.R: A language and environment for statistical computing.2022. <https:\/\/www.R-project.org\/> Accessed: April 7 2023."},{"key":"e_1_2_10_41_1","unstructured":"LavielleM:Rsmlx: R Speaks \u201cMonolix\u201d2022. <https:\/\/CRAN.R-project.org\/package=Rsmlx> Accessed: July 4 2023."},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16178"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978\u20100\u201012\u2010803550\u20104.00028\u20108"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002\u20109343(59)90346\u20108"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12645"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2014.0500114"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045\u2010824X\u20104\u201012"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102213"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701606"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.17085\/apm.2018.13.4.409"},{"key":"e_1_2_10_51_1","first-page":"6","article-title":"Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations","volume":"291","author":"Montfoort JEV","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476\u20105381.2011.01724.x"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03011309"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.16386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T09:40:17Z","timestamp":1752831617000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.16386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1111\/bcp.16386"],"URL":"https:\/\/doi.org\/10.1111\/bcp.16386","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}